Загрузка...
Advancing Novel PrEP Products – Alternatives to Non-Inferiority
With the scale-up of HIV pre-exposure prophylaxis (PrEP) with tenofovir (TDF) with or without emtricitabine (FTC), we have entered an era of highly effective HIV prevention with a growing pipeline of potential products to be studied. These studies are likely to be randomized trials with an oral TDF/...
Сохранить в:
| Опубликовано в: : | Stat Commun Infect Dis |
|---|---|
| Главный автор: | |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6731035/ https://ncbi.nlm.nih.gov/pubmed/31497242 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1515/scid-2019-0011 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|